Literature DB >> 16251391

Imaging of the patient with non-small cell lung cancer.

Reginald F Munden1, Stephen S Swisher, Craig W Stevens, David J Stewart.   

Abstract

Lung cancer is the most common type of cancer and is the leading cause of cancer deaths in the United States for both men and women. Even though the 5-year survival rate of patients with lung cancer remains dismal at 14% for all cancer stages, treatments are improving and newer agents for lung cancer appear promising. Therefore, an accurate assessment of the extent of disease is critical to determine whether the patient is treated with surgical resection, radiation therapy, chemotherapy, or a combination of these modalities. Radiologic imaging plays an important role in the staging evaluation of the patient; however, radiologists need to be aware that there are also important differences in what each specialist needs from imaging to provide appropriate treatment. This article reviews the role of imaging in patients with non-small cell lung cancer, with an emphasis on the radiologic imaging findings relevant for each specialty. RSNA, 2005

Entities:  

Mesh:

Year:  2005        PMID: 16251391     DOI: 10.1148/radiol.2373040966

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

1.  Current status of thermal ablation treatments for lung malignancies.

Authors:  Damian E Dupuy; Maria Shulman
Journal:  Semin Intervent Radiol       Date:  2010-09       Impact factor: 1.513

2.  Improving CT prediction of treatment response in patients with metastatic colorectal carcinoma using statistical learning theory.

Authors:  Walker H Land; Dan Margolis; Ronald Gottlieb; Elizabeth A Krupinski; Jack Y Yang
Journal:  BMC Genomics       Date:  2010-12-01       Impact factor: 3.969

Review 3.  Integrated imaging of non-small cell lung cancer recurrence: CT and PET-CT findings, possible pitfalls and risk of recurrence criteria.

Authors:  Andrea Caulo; Saeed Mirsadraee; Fabio Maggi; Lucia Leccisotti; Edwin J R van Beek; Lorenzo Bonomo
Journal:  Eur Radiol       Date:  2011-10-04       Impact factor: 5.315

Review 4.  Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts.

Authors:  M Reck; F Barlesi; L Crinò; C I Henschke; D Isla; S Stiebeler; D R Spigel
Journal:  Ann Oncol       Date:  2011-11-04       Impact factor: 32.976

5.  Easy Diagnosis of Aortic Invasion in Patients with Lung Cancer Using Cine Magnetic Resonance Imaging.

Authors:  Hidetaka Uramoto; Hiroyasu Kinoshita; Yuki Nakajima; Hirohiko Akiyama
Journal:  Case Rep Oncol       Date:  2015-07-30

6.  Clinical and radiological features driving patient selection for antiangiogenic therapy in non-small cell lung cancer (NSCLC).

Authors:  Cesare Gridelli; Andrea Camerini; Giovanni Pappagallo; Angelo Pennella; Michele Anzidei; Massimo Bellomi; Roberta Buosi; Rosario Francesco Grasso
Journal:  Cancer Imaging       Date:  2016-12-28       Impact factor: 3.909

7.  The major thoracic vascular invasion of lung cancer.

Authors:  Soichi Oka; Shuichi Shinohara; Taiji Kuwata; Masaru Takenaka; Yasuhiro Chikaishi; Ayako Hirai; Yoshinobu Ichiki; Shohei Shimajiri; Takatoshi Aoki; Fumihiro Tanaka
Journal:  Ann Med Surg (Lond)       Date:  2017-06-20

8.  ePAD: An Image Annotation and Analysis Platform for Quantitative Imaging.

Authors:  Daniel L Rubin; Mete Ugur Akdogan; Cavit Altindag; Emel Alkim
Journal:  Tomography       Date:  2019-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.